| 查看: 418 | 回复: 0 | |||
[交流]
The basis of submission中的basis该怎样理解？
|
|
1.Basis of Submission for an ANDA for a Generic Drug that is the Same as its RLD When an applicant submits an ANDA for a generic drug that is the same as its RLD, the basis of submission is the RLD. Accordingly, the name of the RLD, including dosage form and strength, and its application number should be provided as the basis of submission on Form FDA 356h (i.e., the form that accompanies regulatory submissions by an applicant) and in the appropriate sections of the ANDA. 发自小木虫Android客户端 |
回复此楼» 猜你喜欢
FDA核查 研发机构
已经有1人回复
-
国家高层次人才李兴淑教授课题组招收博士研究生
已经有39人回复
-
药理学论文润色/翻译怎么收费?
已经有113人回复
-
己酮可可碱过氧化杂质限度
已经有2人回复
-
求助Isoeugenol质量标准
已经有0人回复
-
Gliclazide
已经有0人回复
-
塞替派/噻替哌（Thiotepa） 质量控制
已经有16人回复
-
有没有大佬可以帮忙查下Trijardy XR和Qternmet XR历年销售数据呀
已经有0人回复
-
酰胺水解求助
已经有11人回复
-
中药材标准目录大全llp2026（含各省市中药材和炮制规范）
已经有0人回复